Why the Mounjaro pen has 5 doses, not 4

What Eli Lilly's own data tell us about the pen's contents

The Mounjaro KwikPen is a single-use, prefilled auto-injector made by Eli Lilly. Its job is to deliver four once-weekly subcutaneous injections, and the pen's construction is set up to guarantee that all four arrive in full. To do that reliably, Eli Lilly fills each pen with slightly more medicine than four exact doses would require. The overfill accounts for the small quantity that primes the needle and ensures the injection mechanism works correctly every time. That overfill is what registers on the dose counter as a fifth position.

This design principle is not unique to Mounjaro; many prefilled injection devices include an overfill for exactly the same reason. What makes the Mounjaro pen slightly unusual is that its dose counter is transparent enough that patients can see the count clearly, which is genuinely useful for tracking, but it also means the fifth position is visible and sometimes confusing. The NHS tirzepatide medicines page and the pen's own Patient Information Leaflet both describe the pen as delivering four weekly doses; the fifth position on the counter is not a fifth therapeutic dose.

If you look at the pen before your first injection and the counter reads 5, the pen is full and correct. After your fourth injection it should read 1, then 0 once empty. A pen reaching 0 before your fourth dose would be unusual and worth raising with your prescriber.

A misconception worth clearing up gently

A fair number of people who start Mounjaro assume that discovering a fifth dose means their pen is overfilled by accident, or that they have been given a pen meant for someone on a different regimen. It is a completely understandable reading of the situation. The pen counter counts down from 5, there are only four weeks in a month, and the arithmetic seems off. In practice, the count simply reflects how the device is built (five positions accommodate four patient doses plus one priming buffer) and every pen, regardless of strength, works the same way.

This matters practically. If you are tracking your supply and mentally expecting each pen to last exactly four weeks, it will, because that is what the pen is designed for. We explain in more detail why there are 5 doses shown in the Mounjaro pen, including what each counter position actually represents and why the fifth is not an injectable dose. Your prescribed dose and titration schedule are set by your prescriber and do not change based on what the counter reads.

If you are ever uncertain about where you are in your schedule (perhaps after a missed week or a delayed delivery) that is exactly the kind of question our prescribers are available to answer through aftercare, seven days a week.

What this means for managing your monthly supply

Because each pen contains four usable weekly doses, your monthly supply is one pen per calendar month on the standard once-weekly schedule. The full breakdown of pen contents by strength follows this same structure across all six available strengths. Whether you are on the 2.5 mg starter pen or a higher maintenance strength, the count from 5 down to 0 works identically.

Practically speaking, the pen should be stored in the fridge between 2°C and 8°C. After removing it, there is a room-temperature storage window before use, the exact duration is specified in the Patient Information Leaflet, and it is worth reading that rather than relying on a third-party summary, because the window varies by circumstance. Always prime the pen as instructed before each injection; if you are wondering whether the Mounjaro pen has an extra dose built in to cover priming, our guide explains exactly how that overfill is used up and why it cannot be injected as a therapeutic dose.

When the counter reaches 0, the pen should go into a dedicated sharps container rather than household waste. The needle tip should be removed after each injection and discarded safely, then replaced with a fresh needle before the next dose, something worth building into your weekly routine early on.

For context on how the different strengths relate to the titration schedule and what your prescriber considers at each stage, the Mounjaro treatment overview covers the broader picture. And if cost is a consideration as you plan ahead, the Mounjaro pricing guide sets out what private treatment typically involves in the UK.

When to speak to a prescriber about your pen

The five-dose counter is straightforward once you know what it represents, but there are situations where the pen's behaviour should prompt a conversation rather than a self-diagnosis. If your pen reaches 0 after fewer than four injections (and you are confident you followed the technique correctly) contact your prescriber or aftercare team. Equally, if you notice anything unusual about the liquid in the pen (cloudiness, particles, discolouration), do not inject it; check the Patient Information Leaflet and speak to a clinician.

Side effects during treatment are worth reporting too. The most common ones are gastrointestinal: nausea, constipation, loose stools and indigestion are all well-documented in the SURMOUNT clinical programme and tend to be most noticeable at the start of a new dose. Severe or persistent stomach pain that radiates to the back is different in character and needs prompt medical attention. The MHRA's Yellow Card scheme is the right place to report any suspected side effect from a medicine, including Mounjaro.

Our clinical team reviews every consultation and repeat order personally. If you have questions about your pen, your schedule or how treatment is going, the free consultation page is where to speak to our prescribers.